Multiple myeloma trials in Croatia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Where

  Rijeka, Zagreb

  Age

  18 years and over

  People

  386 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT05645107 · EU 2022-502193-16-00
• Phase 3Taking people
  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  Where

  Grad Zagreb, Osijek, Rijeka, Split, Zagreb

  Age

  18 years and over

  People

  492 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06152575 · EU 2023-507871-23-00
• Phase 3Taking people
  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  Where

  Zagreb

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  European Myeloma Network B.V.

  See details and how to joinNCT06932562 · EU 2024-519827-16-00